SAN DIEGO--(BUSINESS WIRE)--
Biocom, the association representing the California life science industry, today announced the endorsement of Nathan Fletcher for the San Diego County Board of Supervisors District 4 seat.
“Nathan, a former state assemblyman, has a remarkable record of unprecedented accomplishment working with the life sciences industry,” said Joe Panetta, president and CEO of Biocom. “He offers positive ideas on how he can champion the life science industry and enhance its robust economic impact, and we support his vision for the County. Nathan understands the compelling need to ensure San Diego County leads the nation as one of the most robust life science hubs in the world. We are proud to stand with him and endorse his campaign.”
Prior to his first election to the State Assembly in 2008, Fletcher met with Biocom to discuss its legislative priorities. High on that list was enactment of a single sales factor corporate tax apportionment in California, a formula which rewards companies who invest in California by building facilities and employing Californians. Biocom and other California stakeholders had tried unsuccessfully for many years to enact such a formula. Within three months of being sworn into office, former Assemblyman Fletcher was instrumental in getting single sales factor enacted into law.
“Whoever wins the 4th District seat will have huge shoes to fill,” continued Panetta. “Termed-out Supervisor Ron Roberts has been a stalwart supporter of the life sciences industry in San Diego for many years. A well-functioning, business-conscious San Diego County Board of Supervisors is critical to the life sciences industry, as the Board serves a vital function overseeing local environmental and air quality standards, which impact our industry. Nathan, a former Biocom Elected Official of the Year, is best equipped to provide the County with the leadership it needs.”
Biocom is the largest, most experienced leader and advocate for California’s life science sector. We work on behalf of more than 1,100 members to drive public policy, build an enviable network of industry leaders, create access to capital, introduce cutting-edge STEM education programs, and create robust value-driven purchasing programs.
Founded in 1995 in San Diego, Biocom provides the strongest public voice to research institutions and companies that fuel the local and state-wide economy. Our goal is simple: to help our members produce novel solutions that improve the human condition. In addition to our San Diego headquarters, Biocom operates core offices in Los Angeles and the San Francisco Bay Area, satellite offices in Washington, D.C. and Tokyo, and has a continuous staff presence in Sacramento. Our broad membership benefits apply to biotechnology, pharmaceutical, medical device, genomics and diagnostics companies of all sizes, as well as to research universities and institutes, clinical research organizations, investors and service providers.